Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The recent study underscores the limited eligibility for new monoclonal antibody treatments in early Alzheimer’s patients, emphasizing the need for more inclusive research. Explore the detailed findings to understand the implications for treatment availability in diverse populations.
Neurology August 22nd 2023
British Medical Journal (The BMJ)
This multinational study offers a comprehensive analysis of the association between protracted low dose exposure to ionising radiation and solid cancer mortality. Physicians and healthcare professionals may find the results significant in understanding and enhancing radiation protection, especially in contemporary medical settings.
Oncology, Medical August 21st 2023
JAMA Network
Recent findings suggest a potential association between the school calendar and suicidality rates among children and adolescents, especially in light of disruptions observed during the COVID-19 pandemic.
Emergency Medicine August 8th 2023
Cancer Care Business Exchange (CBEx)
The chemotherapy shortage in the US is a pressing issue that demands a reevaluation of health policies. Dive deeper into the potential strategies for mitigating its impact, from creating a market for high-quality generics to convening a multi-stakeholder task force.
Oncology, Medical August 7th 2023
Medical Professionals Reference (MPR)
The potential shortage of Saxenda (liraglutide) through 2023 underscores the importance of monitoring the availability of this weight management drug. Physicians should be aware of this situation and consider alternative options if necessary.
Endocrinology, Diabetes, Metabolism August 3rd 2023
Journal of Pharmaceutical Policy and Practice
The first of its kind in Cyprus, this study underscores a prevailing lack of public knowledge regarding paracetamol, including misunderstandings about its composition and concerning practices such as combining it with alcohol.
Clinical Pharmacology July 31st 2023